What are the indications for using levosimendan in heart failure patients?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18417008
Cited by: 0

Abstract

Levosimendan is indicated for acute and chronic heart failure settings, especially in cases of reduced ejection fraction and postoperative cardiac surgery, owing to its hemodynamic benefits, although concerns about its adverse effects remain.

Fields of Study & Subjects

Heart Failure Treatment and Management Mechanical Circulatory Support Devices Cardiovascular Function and Risk Factors

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
29 January 2026